[Toxic maternal dose of bupivacaine during fetoscopic treatment of twin-to-twin transfusion syndrome].
Plaza Moral
A M
AM
de Fernández Lopez Hierro
C
C
Pons Casaovas
M
M
Gomar Sancho
C
C
D000007:Abdominal Injuries / Q000209:etiology; D000327:Adsorption; D000328:Adult; D000772:Anesthesia, Local; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D002045:Bupivacaine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D003128:Coma / Q000139:chemically induced*; D016292:Procedural Sedation; D005260:Female; D005313:Fetal Death / Q000209:etiology; D005330:Fetofetal Transfusion / Q000601:surgery*; D005332:Fetoscopy; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000627:therapeutic use; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D017075:Laser Coagulation; D009207:Myoclonus / Q000139:chemically induced*; D009215:Myometrium / Q000098:blood supply / Q000293:injuries; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use; D010920:Placenta / Q000098:blood supply; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced*; D011677:Punctures / Q000009:adverse effects*; D000077208:Remifentanil; D014313:Trismus / Q000139:chemically induced
D000779:Anesthetics, Local; D006993:Hypnotics and Sedatives; D010880:Piperidines; D000077208:Remifentanil; D002045:Bupivacaine